A carregar...
Bosutinib for Chronic Myeloid Leukemia
In recent years the availability of several tyrosine kinase inhibitors (TKI) in the therapeutic armamentarium for chronic myeloid leukemia has dramatically changed the objectives and expectations of healthcare providers and patients. For many, but not all, patients the forerunner of TKI, imatinib, i...
Na minha lista:
| Publicado no: | Rare Cancers Ther |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer Healthcare
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4837934/ https://ncbi.nlm.nih.gov/pubmed/27182477 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40487-015-0010-y |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|